Genetic mutations in GSTs, mainly the null genotype of GSTT1 and GSTM1 are considered a risk factor for breast cancer [16,17], but little is known about the presence of these polymorphisms and age at the diagnosis of breast cancer. Here, HPGDS is linked to breast cancer.